Seasonal influenza vaccine - Chengdu Kanghua Biological Products
Latest Information Update: 30 Oct 2021
At a glance
- Originator Chengdu Kanghua Biological Products
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Oct 2018 No recent reports of development identified for clinical-Phase-Unknown development in Influenza-virus-infections in China (Parenteral, Injection)
- 04 Sep 2015 Clinical trials in Influenza virus infections in China (Parenteral) before September 2015